Restricted for initiation until after a discussion with liaison psychiatry team.
Restricted for initiation by a Consultant Psychiatrist only.
(hospital only prescribing) for aripiprazole intramuscular injection
for aripiprazole oral formulations
Approved (7.5mg/1mL IM formulation) for the rapid control of agitation and disturbed behaviours in adult patients with schizophrenia or with manic episodes in Bipolar I Disorder when oral therapy is not appropriate and where IM haloperidol is not recommended (JFC January 2019).
As per indication stated above for IM formulation, after psychiatry advise only
Oral formulations are on the formulary for CONTINUATION ONLY. Not to be initiated at NMUH
Restricted for initiation until after a discussion with liaison psychiatry team
Initiation with Psychiatry advice only
Restricted for initiation by a Consultant Psychiatrist only
Persistent aggression in moderate to severe Alzheimer’s dementia where risk of harm to self & others (off-label)
Depression (adjunctive treatment)
Challenging behaviour in learning disabilities - 2nd line
Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.
Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.
Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.
Medicines which should normally be prescribed by specialists only (hospital only).
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.